Health
Health portfolios focus on the medical and health-care industries. Most invest in a range of companies, buying everything from pharmaceutical and medical-device makers to HMOs, hospitals, and nursing homes. A few portfolios concentrate on just one industry segment, such as service providers or biotechnology firms. Morningstar®
#31 Manning & Napier Life Sciences Series Fund (EXLSX)
| Performance (1-yr.): 15.67% | Expenses: 1.12% |
| Performance (1-mo.): 0.36% | Total Assets: $251.1M |
#32 Eaton Vance Worldwide Health Sciences Fund (ETHSX)
| Performance (1-yr.): 22.14% | Expenses: 1.41% |
| Performance (1-mo.): 3.16% | Total Assets: $1.09B |
Eventide Healthcare & Life Sciences Fund (ETAHX)
| Performance (1-yr.): — | Expenses: 1.69% |
| Performance (1-mo.): 3.12% | Total Assets: $3.08M |
Hartford Healthcare HLS Fund (HIAHX)
| Performance (1-yr.): 26.98% | Expenses: 0.91% |
| Performance (1-mo.): 3.83% | Total Assets: $239.82M |
ING BlackRock Health Sciences Opportunities Portfolio (IEHSX)
| Performance (1-yr.): 30.31% | Expenses: 1.02% |
| Performance (1-mo.): 2.36% | Total Assets: $316.73M |
John Hancock II Health Sciences Fund (None)
| Performance (1-yr.): 30.22% | Expenses: 1.14% |
| Performance (1-mo.): 3.15% | Total Assets: $531.51M |
John Hancock Variable Insurance Trust Health Sciences Trust (JEHSX)
| Performance (1-yr.): 30.53% | Expenses: 1.18% |
| Performance (1-mo.): 3.19% | Total Assets: $219.46M |
VALIC Company I Health Sciences Fund (VCHSX)
| Performance (1-yr.): 30.50% | Expenses: 1.16% |
| Performance (1-mo.): 3.21% | Total Assets: $397.07M |
